Drug Development

Articles

Creating an inhaled formulation is one way in which improved efficacy or added value can be achieved in projects to repurpose or reposition existing drugs.

Key Considerations When Repositioning a Known Drug for Inhalation Therapy

Negotiations for a final advance purchase agreement where the Government of Canada purchases the vaccine candidate on a not-for-profit basis for emergency pandemic use are underway. 

J&J to Supply the Government of Canada with Doses of its COVID-19 Vaccine Candidate

The vaccine will be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical starting in the first half of 2021 if the vaccine candidate receives regulatory approval.

Moderna in Discussions to Supply Japan with Doses of its COVID-19 Vaccine Candidate

Novavax and the Government of Canada will finalize an advanced purchase agreement under which Novavax will supply doses of NVX-CoV2373 to Canada beginning in the second quarter of 2021.

Novavax to Supply Canada with Doses of its COVID-19 Vaccine Candidate 

The Ventofor Combi Fix will be brought into the Turkish market via Bilim’s development program, while the PowdAir Plus DPI is manufactured and commercialized by H&T Presspart under a patent license from Hovione.

Bilim, H&T Presspart, and Hovione Partner to Bring Asthma Product to the Turkish Market

Oxford Biomedica will reserve capacity for AstraZeneca in three of its manufacturing suites in its new commercial manufacturing center, Oxbox, for 18 months. 



Oxford Biomedica Collaborates with AstraZeneca for COVID-19 Vaccine Candidate Manufacturing

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.

AbCellera’s Acquisition of OrthoMab Bispecific Platform Propels Antibody Development

In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.

GigaGen Highlights Research Describing New Class of Drugs for Potential COVID-19 Therapy

The contract is valued at $106.3 million and is supported by Operation Warp Speed.

Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19 Vaccines and Therapeutics

The European Commission (EC) and Moderna have concluded exploratory talks on the potential purchase of Moderna’s COVID-19 vaccine candidate for Europeans.

Formulation and Drug Delivery